Russia Defends Anti-Viral Drug as COVID-19 Death Toll Passes 11,000 Russia Defends Anti-Viral Drug as COVID-19 Death Toll Passes 11,000
Russia moved to defend its Avifavir anti-viral drug on Friday following an inconclusive clinical trial in Japan that tested it against COVID-19 and as the country ' s total death toll from the infection surpassed 11,000.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Clinical Trials | COVID-19 | Infectious Diseases | Intensive Care | Japan Health | Russia Health